ForeseeHome Patient
Published by: NOTALVISION,INC
Description
ForeseeHome, a product of Notal Vision, is a home-based ophthalmology diagnostic device that can detect wet Macular Degeneration earlier to help preserve your vision. The patient app allows you to review your testing reports, learn more about macular degeneration and the ForeseeHome program, and contact us
Hide
Show More...
Screenshots
ForeseeHome Patient FAQ
-
Is ForeseeHome Patient free?
Yes, ForeseeHome Patient is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is ForeseeHome Patient legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does ForeseeHome Patient cost?
ForeseeHome Patient is free.
-
What is ForeseeHome Patient revenue?
To get estimated revenue of ForeseeHome Patient app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Colombia yet.
Ratings History
ForeseeHome Patient Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
ForeseeHome Patient Installs
Last 30 days
ForeseeHome Patient Revenue
Last 30 daysForeseeHome Patient Revenue and Downloads
Gain valuable insights into ForeseeHome Patient performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- NOTALVISION,INC
- Languages
- English
- Recent release
- 1.35 (1 year ago )
- Released on
- Apr 23, 2018 (6 years ago )
- Also available in
- United States, India, Pakistan, Japan, South Korea, Kuwait, Kazakhstan, Lebanon, Lithuania, Mexico, Malaysia, Nigeria, Netherlands, Norway, New Zealand, Peru, Philippines, South Africa, Poland, Portugal, Romania, Russia, Saudi Arabia, Sweden, Singapore, Thailand, Türkiye, Taiwan, Ukraine, Vietnam, United Arab Emirates, Denmark, Argentina, Austria, Australia, Azerbaijan, Belgium, Brazil, Belarus, Canada, Switzerland, Chile, China, Colombia, Czechia, Germany, Italy, Dominican Republic, Algeria, Ecuador, Egypt, Spain, Finland, France, United Kingdom, Greece, Hong Kong SAR China, Hungary, Indonesia, Ireland, Israel
- Last Updated
- 3 weeks ago